Lifespan

By David A. Sinclair

10 min read

Why does it matter? Because the line between 'natural aging' and 'treatable disease' is cultural, not biological — and we chose the wrong side.

You've never consciously decided that the last two decades of life should look the way they do. The gradual disappearance of someone you love, the cascade of diagnoses, the years of managed decline before a death that feels anything but peaceful — you absorbed this as the cost of getting old. Sad. Natural. Just the way it goes.

In 2010, nineteen of the world's leading aging researchers concluded something medicine has never acted on: that aging is the disease generating nearly every other condition on a death certificate. David Sinclair's argument is that every dollar spent fighting cancer or heart disease alone is a poor investment. The framing of aging as inevitable is not a biological finding. It's a cultural assumption. And it's the costliest blind spot in the history of medicine.

The Final Years of Life Are Not Life — And We've Agreed to Call That Normal

They had been laughing about a eulogy just moments before. David Sinclair had flown from the United States to Australia to see his mother Diana, and they were sharing one of those moments families steal near the end: warmth, dark humor, the relief of being together. Then Diana was writhing on the bed, gasping for air her body couldn't use, her eyes locked on her son with a desperation that had no words.

He leaned in close and told her she was the best mother he could have wished for. Within minutes, her neurons were shutting down, erasing everything: every place she'd been, every person she'd loved, every memory of raising him. She had become, in his telling, a body stripped to its chemistry: cells fighting over the last scraps of energy, the woman who had raised him already gone.

What stayed with him afterward was the silence around it. Nobody tells you what dying actually looks like. We carry a comfortable fiction: the gentle fade, the family gathered, the peaceful departure. Claude Lanzmann, the filmmaker who spent thirty years recording the mechanics of mass death, arrived at a harsher verdict: there is no natural death. Every death is violent. We simply choose not to believe it.

Sinclair looks past the moment of death to the decade that precedes it. His grandmother Vera — who distributed anti-Communist newsletters in Budapest during the 1956 uprising, wore what may have been Australia's first bikini on Bondi Beach, and lived alone in the jungles of New Guinea — spent her final years unable to rise from her chair. Music no longer moved her. The aliveness that had defined her was gone. "This is just the way it goes," she told him.

That sentence is the problem. The acceptance of decline as inevitable, the cultural shrug that never asks whether it has to be this way, has become our civilization's quiet agreement. We call this wisdom.

Cloning Proves Your DNA Is Young. So Something Else Is Aging You.

Think of your cells as DVD players. The disc inside, your DNA, contains the complete instructions for building a young, functioning body. The player, your epigenome, reads that disc and decides which genes to run in which cells. Over time, the player accumulates scratches. The disc is unchanged. But the player keeps misreading it: playing the wrong track, skipping sequences it should execute, looping ones it should leave alone.

The question that cracked open Sinclair's understanding of aging was this: why can scientists clone healthy animals from the cells of old ones? When Dolly the sheep was cloned from an adult cell and later died young, many assumed cloned animals inherit the damage of their source. Pathologists who examined Dolly found no signs of accelerated aging. She died from a lung disease prevalent in her facility. Goats, cows, and mice, all cloned from adults, all lived normal lifespans. An old body's DNA still carries everything required to build a completely new one.

Mutations in DNA can't be the primary driver of aging. If they were, the disc would be broken, and you can't make a healthy copy from a broken disc.

What ages is the player. The epigenome is a layer of chemical tags and protein packaging controlling which genes get expressed in which cells: the software running on the genetic hardware. Every time a DNA strand breaks and gets repaired, the sirtuin proteins managing gene expression abandon their posts to help fix the damage, then return to positions slightly off from where they started. The wrong genes switch on. Cells gradually lose their identity, becoming miscellaneous where they used to be precise.

To test whether this was causing aging, not just accompanying it, Sinclair's lab engineered mice with an enzyme borrowed from slime mold that could cut DNA in regions containing no functional genes at all. The cuts healed without mutations. Pure disruption, no permanent alteration to the genome. A few months later, a postdoc called Sinclair to report that one of the mice looked dangerously ill and might need to be put down. He asked her to text him a photo. He looked at it and laughed: the mouse wasn't sick. At sixteen months — roughly a human sixty-five — it had thinning gray hair, a curved spine, cloudy eyes, and ears thin as paper. Its littermates, same age, same cage, looked perfectly normal. No altered DNA, no shortened telomeres, no mitochondrial damage. Just epigenetic noise, accumulating at fifty percent above the normal rate.

The disc was untouched. The player was reading it wrong.

We Fund the 5x Risk. We've Ignored the 1,000x One for Decades.

The single biggest risk factor for cancer, heart disease, and dementia is the one nobody is funding. Smoking triggers chemical changes in DNA that increase your cancer risk roughly fivefold, and the world has responded with cessation programs, warning labels, and taxes that cost billions to run. Being fifty years old multiplies that same cancer risk by a hundredfold. Being seventy takes it to a thousandfold. No country has committed serious resources to the age risk. The imbalance is not a rounding error. It is the operating premise of modern medicine.

You might assume the logic still holds: if medicine fights the diseases aging produces, the root cause gets addressed eventually. Sinclair shows why this doesn't work. The arithmetic is blunt. If cardiovascular disease were completely eradicated (every single case, gone), average lifespan would extend by 1.5 years. The same for all forms of cancer combined: 2.1 years. The reason is that aging compounds exponentially: your probability of dying from something doubles roughly every eight years after fifty. Remove heart disease, and cancer accelerates to fill the gap. Remove cancer, and dementia climbs.

The failure is structural. Hospitals divided by organ, research funded by diagnosis, drugs developed for single conditions: the whole architecture assumes that defeating aging means defeating its symptoms in sequence. The math says that's not what happens. The exponential curve is the disease. The named conditions are simply where it surfaces in whoever it finds first.

The definitional problem compounds everything. A condition affecting fewer than half the population qualifies as a disease, so it can attract research funding, pharmaceutical development, and insurance coverage. Aging affects everyone, so it's officially classified as "inevitable, irreversible decline." That puts it off the map for the research and financial infrastructure built to fight disease. It clears every clinical threshold for a disease diagnosis except prevalence. It produces physical decline. It limits quality of life. It follows a known and worsening pathology. We've simply agreed to accept it at the point where it becomes universal — which is exactly the moment when the word "inevitable" does its most damaging work.

The Survival Circuit Already Built Into Your Cells Is Waiting to Be Switched On

What if the survival mechanism is already built in — not a future therapy, but a circuit that already exists in every cell, waiting for the right signal?

Sinclair calls it a survival circuit: a suite of ancient genes that evolved to help organisms endure scarcity. When food runs short, muscles strain, or the body goes cold, these genes switch on: tighter epigenetic control, more efficient DNA repair, slower accumulation of informational noise. For most people living comfortable modern lives, this circuit rarely fires. We evolved for intermittent hardship. We've arranged things so none arrives.

Certain molecules can activate that circuit without the hardship. Metformin (a diabetes drug derived from French lilac, available for under five dollars a month) limits energy conversion in mitochondria, tricking AMPK, an enzyme that reads low energy as a stress signal, into switching on cellular defenses: the sirtuin pathway, the same one engaged by calorie restriction and exercise. A study of more than forty thousand metformin users aged sixty-eight to eighty-one found nineteen percent less cardiovascular disease, twenty-four percent less frailty, meaningful reductions in dementia and cancer. NMN, found in avocado and broccoli and converted by the body to NAD, fuels those sirtuin enzymes more directly. A week of NMN injections in old mice made their mitochondria function like those of young mice.

Sinclair's father is the data point he can't publish. A biochemist by training but a desk worker by disposition — an Eeyore of a man who expected a decade of retirement and then a nursing home — he arrived at his mid-seventies with type 2 diabetes, failing hearing and vision. He started metformin. A year later, NMN. Six months in, something shifted: less fatigue, less pain, sharper thinking. His liver enzymes, abnormal for twenty years, normalized. Then came the harder-to-explain part: hiking six days through Tasmanian snow, whitewater rafting in Montana, Austrian ice caves. He took on new work at a university ethics committee. "I'm outpacing my friends," he told Sinclair. "They can't come on walks with me anymore."

Sinclair is explicit: this is anecdotal, uncontrolled, possibly coincidental. His father is a scientist and says the same. Then he shrugs — "there's really no other explanation."

That shrug matters. These molecules are targeting a real pathway, with real evidence from animal and human trials. The question of whether the survival circuit can be switched on through chemistry that mimics the stress signal — without the actual starvation or cold — is no longer speculative. It's being tested. And one Harvard geneticist found the preliminary evidence convincing enough that he's watching it unfold in his own family.

A Graduate Student Grew Back the Nerve That Biology Said Could Never Heal

Yuancheng Lu walked into David Sinclair's office in 2016 ready to quit. Two years of trying to reverse the aging clock in cells had produced the same result every time: tumor. The culprit was likely c-Myc, one of four genes Nobel laureate Shinya Yamanaka had shown could strip a cell of its age and return it to an unspecialized, youthful state. As a final act before walking away, Lu asked if he could try leaving c-Myc out.

Sinclair said yes. Lu delivered a virus carrying only the remaining three factors into mice, activated them with an antibiotic called doxycycline, and waited for the animals to sicken. None did. Months passed. No tumors.

Then Lu proposed testing the reprogramming on optic nerves, which Sinclair told him was the hardest problem in biology. Unlike the nerves in your arms and legs, which can slowly regrow, the optic nerve belongs to the central nervous system. It doesn't regenerate. Decades of attempts had produced nothing. Sinclair told Lu he'd picked the worst possible target.

"But if we could solve that problem," Lu said.

They crushed the optic nerves of mice and delivered the three-factor virus. A few months later, Sinclair received a text: a fluorescent microscope image showing a glowing, jellyfish-like form — the nerve fibers of a mouse eye, stained so only living neurons lit up, extending below the crush site toward the brain in long, healthy filaments. Where there had been dead remnants, there was growth. Sinclair called immediately. "Am I seeing what I think I'm seeing?" He told Lu what he saw. "The future."

Confirmation came from Bruce Ksander at Massachusetts Eye and Ear. He'd agreed to test the virus on normally aged mice (the slow vision loss that builds over a lifetime, not artificially damaged tissue), but told Sinclair he'd almost not bothered running the controls; he never expected it to work. The three-factor virus had restored vision in aged mice. His colleague Meredith Gregory-Ksander then showed the same treatment reversed vision loss from glaucoma.

If aged optic neurons — a structure biology had declared permanently beyond repair — can be rewound, the list of tissues beyond repair starts to look like a list of tissues no one has tried yet.

Victorian London Was Collapsing Under Too Many People. Then It Tripled in Size and Fixed the Problem.

Imagine standing in London in 1866, surveying ankle-deep manure in the streets, three cholera outbreaks in thirty years, sewage draining into the same river the poor drank from. Hundreds were dying in Soho every single day. The city felt past whatever threshold of human density it could sustain. What would you have predicted?

London then held three million people. Today it holds nine million, with a fraction of the disease and death. The crisis forced the city's hand: public housing, mandatory schooling, and a complete sanitation overhaul after physician John Snow showed that removing the pump handle ended an epidemic. Those solutions were copied around the world and extended more healthy years of life to more people than any medical intervention since. The problem was never how many people lived in London. It was how they lived.

The same logic applies to longevity, and the same objections get raised.

The objections to longer human lives are real. Political systems calcify around their oldest constituents — one US senator served until he was 100, opposing civil rights until the end. Social insurance programs have no mathematical model for retirements lasting sixty years. And if longevity treatments arrive as expensive luxuries, the thirteen-year life expectancy gap between rich and poor Americans (already true today) could widen into something resembling two separate species. These are honest extrapolations of the current trajectory.

USC economist Dana Goldman ran the numbers on what actually changes the trajectory. Fighting diseases one at a time leaves the exponential curve intact. Attack any single disease and the next one accelerates to fill the vacancy. Delay aging itself, and every fatal and disabling condition retreats simultaneously. Conservative estimate: seven trillion dollars in US economic benefit over fifty years. The molecules that do this already exist. The science is in motion. The only missing piece is the word: call aging a disease, and the resources are finally allowed to follow.

The Question That Changes What the Next Decade Looks Like

Everything you've been told about the final decades of life — the slow retreat, the diminishing returns, the dignified surrender — rests on a single word: inevitable. The researchers who signed that 2010 paper weren't being optimistic. They were being precise. The science since has not been kind to that word.

Sinclair's father is not proof of anything. He'll say so himself. But he's hiking through Tasmanian snow at eighty, showing up for the moments that matter, outpacing friends a decade younger. The metformin in a five-dollar pill and the NMN in an avocado that switched something back on in him already exist.

You don't need to want immortality. You just need to ask, once, whether this is just the way it goes is a law of biology — or a definition nobody examined until now.